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Abstract
Background:  The RNA-binding protein Sam68 has been implicated in a number of cellular
processes, including transcription, RNA splicing and export, translation, signal transduction, cell
cycle progression and replication of the human immunodeficiency virus and poliovirus. However,
the precise impact it has on essential cellular functions remains largely obscure.
Results: In this report we show that conditional overexpression of Sam68 in fibroblasts results in
both cell cycle arrest and apoptosis. Arrest in G1 phase of the cell cycle is associated with
decreased levels of cyclins D1 and E RNA and protein, resulting in dramatically reduced Rb
phosphorylation. Interestingly, cell cycle arrest does not require the specific RNA binding ability of
Sam68. In marked contrast, induction of apoptosis by Sam68 absolutely requires a fully-functional
RNA binding domain. Moreover, the anti-cancer agent trichostatin A potentiates Sam68-driven
apoptosis.
Conclusions: For the first time we have shown that Sam68, an RNA binding protein with multiple
apparent functions, exerts functionally separable effects on cell proliferation and survival,
dependent on its ability to bind specifically to RNA. These findings shed new light on the ability of
signal transducing RNA binding proteins to influence essential cell function. Moreover, the ability
of a class of anti-cancer therapeutics to modulate its ability to promote apoptosis suggests that
Sam68 status may impact some cancer treatments.
Background
Sam68 (Src associated in mitosis, 68 kDa) was first iden-
tified as a mitosis-specific substrate and binding partner of
activated forms of the Src tyrosine kinase [1,2]. It has since
been shown that it can bind to a variety of other signaling
proteins through SH2, SH3 and WW domain-mediated
interactions, suggesting a possible role as an adaptor pro-
tein [3-7]. It is a nuclear protein and contains a functional
nucleic acid binding domain comprising a K homology
(KH) module located within a larger "GSG" domain,
which is present in Grp-33, Sam68 and Gld-1. This is
required and sufficient for high-affinity binding to specific
RNA sequences in vitro [8,9] and also mediates protein-
protein interactions [10-12] and subnuclear localization
[13,14]. Although Sam68 has so far only been shown to
bind to RNA with sequence specificity [9], it remains pos-
sible that specific binding to single-stranded DNA may be
biologically relevant.
Consistent with its in vitro binding of RNA, Sam68 has
been implicated in processes linked to RNA usage and
gene expression, including splicing [15-17] RNA export
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[18,19] and translation [20]. A role in transporting
unspliced transcripts was suggested by finding that it
could enhance function of the Rev protein of HIV, which
promotes export of unspliced viral RNA through interac-
tion with a Rev response element (RRE), and that a trun-
cation mutant of Sam68 might act as a dominant
inhibitor of Rev function [18,19]. Because of this, it has
been suggested that Sam68 acts as a cellular analog of Rev.
However, Sam68 can also drive expression from reporter
plasmids in which the RRE has been deleted [21], and
recent evidence suggests that Sam68 may stimulate pro-
tein expression without effect on RNA export [20]. In
these studies Sam68 was shown to increase protein
expression from RNA containing the constitutive trans-
port element (CTE) of simpler retroviruses without affect-
ing RNA transport. Instead, Sam68 appeared to stimulate
RNA utilization in the cytoplasm.
Mutation of a conserved residue in the KH domain that
renders Sam68 incapable of specific RNA binding in vitro
abolished this effect, indicating a functional role of RNA
binding. Moreover, its ability to promote cytoplasmic
RNA utilization was inhibited by the Brk/Sik tyrosine
kinase [20]. A recent study also suggests that Sam68 may
play a role in transducing extracellular signals that regu-
late splicing [17]. It was shown that overexpression of
Sam68 enhanced inclusion of exon v5 of CD44 in
response to activation of the Ras-Erk pathway and that
this was dependent on phosphorylation of Sam68 by acti-
vated Erk. These observations raise the possibility that
Sam68 may integrate and transduce signals from cytoplas-
mic signaling pathways to control RNA utilization in a
manner analogous to the role of p300/CBP in transcrip-
tional regulation. Interestingly, Sam68 can physically
interact with CBP [21].
Sam68 also has RNA binding-independent functions. It
was recently shown that it can repress transcription from
reporter constructs in a manner independent of RNA
binding [21]. This, and other aspects of its control of gene
expression, may in part reflect Sam68's ability to interact
with proteins acting at different stages of gene expression,
including the transcriptional co-activator CBP [21], the
multi-functional DNA/RNA binding protein hnRNP K
[22], and the splicing factor YT521-B [16]. It is not clear at
which, and at how many, levels Sam68 exerts its effects on
gene expression; the cellular consequences of these effects
are also unknown. A role in control cell proliferation was
predicted from its cell cycle dependent tyrosine phospho-
rylation [1,2]. Interestingly tyrosine phosphorylation of
Sam68 by Src or Brk tyrosine kinases, or binding of Sam68
to the Src SH3 domain, decreases Sam68's ability to bind
to homopolymeric or specific RNA in vitro [4,6,23], and
downregulation of Sam68 may be important for signaling
or transformation by these kinases. Consistent with this is
the finding that antisense-mediated reduction of Sam68
expression transforms mouse fibroblasts [24]. On the
other hand, deletion of sam68 in a chicken B cell line sup-
pressed growth by elongating G2-M phase [25]. It has also
been reported that expression of an RNA-binding-defec-
tive apparent splice variant of Sam68 lacking part of its
KH domain can restrict G1/S progression, but that wild-
type (wt) Sam68 does not, and that co-transfection of wt
Sam68 eliminates the restriction induced by the splice-
variant [26].
These reports of the biological effects of wt Sam68 seem
somewhat contradictory and bear further examination.
Because of the suggestion that Sam68 may exert a negative
influence on growth (i.e., the anti-sense experiments), we
studied the biological effects of wt and specific-RNA bind-
ing-defective Sam68 using an inducible expression system
that allowed us to stably transfect cells with uninduced
expression plasmids, thereby avoiding potential negative-
selection effects. We found that expression of Sam68 con-
ferred proliferative arrest and apoptosis, and that these
effects were functionally separable based on the require-
ment for specific RNA binding by Sam68.
Results
Sam68 confers proliferative arrest in the absence of 
specific RNA binding
To study the effect of overexpression of Sam68 on cell
function we attempted to generate NIH 3T3 cell lines sta-
bly overexpressing Sam68. However, we were unable to
obtain any overexpressor clones, suggesting that Sam68
overexpression suppressed growth. We therefore estab-
lished "tet-off" NIH 3T3-derived cell lines in which expres-
sion of wt or specific-RNA binding-defective Sam68 could
be repressively controlled by doxycycline (Fig. 1A). We
chose to study a mutant of Sam68 in which Gly178 in the
KH domain is substituted by Glu (G178E) as a potential
loss of function mutant, rather than deletion mutants, for
the following reasons: 1) The G178E substitution mimics
a mutation in the C. elegans gld-1 tumor suppressor gene
which is sufficient for loss of Gld-1 function and tumor
formation [28]. 2) We previously showed that
Sam68G178E did not bind in vitro-selected, high affinity
Sam68 RNA ligands, but bound to homopolymeric RNA,
whereas KH domain deletion mutants did not bind to
either ligand [9]. These two observations indicate that loss
of high affinity, specific RNA binding is sufficient for loss
of protein function. 3) KH domain deletion, but not the
G178E substitution, compromises Sam68 self-interaction
[8] and results in mislocalization of Sam68 within the
nucleus [13,14], which complicates the interpretation of
data obtained with such proteins.
We first assessed the effect of Sam68 overexpression on
cell proliferation: The cell lines were cultured at sub-con-BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/5
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Sam68 overexpression inhibits cell proliferation independently of RNA binding Figure 1
Sam68 overexpression inhibits cell proliferation independently of RNA binding. A. Tet-off cells conditionally 
expressing wild-type (WT) or RNA binding-defective (G178E) HA-epitope tagged Sam68 were grown in the presence or 
absence of 100 ng/ml doxycycline for 24 h. HA-Sam68 expression was assessed by immunoblotting with anti-HA antibody. B. 
Cells conditionally expressing wt or G178E HA-Sam68 or no cDNA (neo) were plated at low density and cultured in the pres-
ence or absence of doxycycline. Adherent cells were collected by trypsinization and counted at the indicated times after plat-
ing. Results are representative of three separate experiments.
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fluence in the presence or absence of doxycycline and
adherent cells were counted over 7 days (Fig 1B). The rate
of proliferation of the tet-off wt or G178E Sam68-express-
ing cells was dramatically decreased in the absence of dox-
ycycline. The number of cells overexpressing wt Sam68
actually decreased over 4 d, indicating Sam68-induced
cell death. Since wt, but not G178E Sam68, provoked cell
death, it was not possible to compare the relative effective-
ness of the two proteins in retarding proliferation.
Removal of doxycycline had no effect on the rate of pro-
liferation of control cells that had been selected with an
empty vector (neo; top panel).
It was previously reported that an RNA binding-defective,
apparent, splice variant of Sam68 lacking part of the KH
domain was able to compromise G1 phase progression,
but that wt Sam68 could not [26]. Our results with wt
Sam68 seemed at variance with those studies, so we exam-
ined the effect of overexpression of wt Sam68 or specific-
RNA binding-defective Sam68G178E on the G1 to S
phase transition. Following brief induction, or not, of
Sam68 expression, cells were synchronized in mitosis by
treatment with nocodazole and then released into G1 by
drug washout. DNA synthesis was measured by BrdU
incorporation (Fig. 2A). Twenty-four hours after release
from mitosis most uninduced cells had incorporated
BrdU and were in the subsequent G2/M or G1 phases, as
determined by propidium iodide staining (data not
shown). Overexpression of wt Sam68 reduced the
number of BrdU positive cells from 89% to 24%, indicat-
ing G1 delay or arrest. Moreover, most of the BrdU posi-
tive cells were still in S phase, suggesting that the
preceding G1 phase had been extended.
Overexpression of Sam68G178E also decreased the
number of BrdU positive cells; from 87% to 53%. The
lesser effect of this mutant may reflect an additional spe-
cific-RNA binding-dependent effect on G1 progression.
Nonetheless, it is clear that this mutant severely inhibits
proliferation and G1 passage. Immunoblotting 8 h after
mitotic release showed that expression of wt or mutant
Sam68 reduced the levels of cyclins D1 and E (Fig. 2A, top
three panels, dox-lanes). [The clone expressing
Sam68G178E appeared to express a higher level of cyclin
D1 in the uninduced state (Fig. 2A, top panel, dox+ lanes),
which may further explain the weaker ability of this
mutant to inhibit G1 progression.]
To determine if the G1 cyclins were down-regulated by
control of their RNA levels, we measured these levels by
RT-PCR (Fig. 2B). Cyclin D1 transcript levels were reduced
in cells overexpressing Sam68, most notably at 9 h after
mitosis (late G1). However, levels of the related cyclin D2
RNA were unchanged by Sam68 overexpression. The nor-
mal increase in Cyclin E RNA level noted 9 h after release
from mitosis in uninduced cells was abolished by induc-
tion of Sam68. These Sam68-induced changes in cyclin
RNA levels are sufficient to explain the observed changes
in cyclin protein levels.
To follow the consequences of cyclin D1 and E downreg-
ulation we compared the kinetics of the cyclin level
changes with the activities of G1 cyclin-dependent kinases
and the phosphorylation of Rb following release from
mitosis or G0 into G1. Cells were synchronized in mitosis
with nocodazole or in G0 by serum withdrawal and
released by drug removal or serum replacement, respec-
tively. Cyclin expression levels were determined by immu-
noblotting (Fig. 3A). In agreement with the RNA level
changes (Fig. 2B), cyclin D1 levels were high in mitotic
cells and stayed at the same levels in uninduced cells dur-
ing G1 progression. Also in agreement, cyclin D1 expres-
sion was lower in mitotic cells overexpressing Sam68 and
was barely detectable 5 and 10 h after release from mito-
sis. As expected, cyclin D1 levels were low in serum-
starved cells and increased after 10 and 15 h of serum
treatment of uninduced cells. This increase was reduced in
cells overexpressing Sam68. Cyclin E was not detectably
expressed in mitotic cells but expression in uninduced
cells increased 5 and 10 h after release. This increase was
substantially blocked by overexpressed Sam68. Sam68
overexpression had no noticeable effect on cyclin E levels
in the serum-treated cells; this may be due to the much
lower levels of Sam68 in the serum-depleted cells com-
pared to the cells released from mitosis (Fig. 3A, top
panel).
Cdk2 activity was indirectly determined by immunoblot-
ting and examining the downward gel shift that accompa-
nies its activation. Whereas there was a substantial
increase in the level of downshifted Cdk2 10 h after
release from mitosis in uninduced cells, this was abol-
ished in the induced cells (Fig. 3A). There was also a small
but noticeable decrease in Cdk2 activation in late G1 after
serum stimulation, in spite of the unchanged cyclin E lev-
els in these cells.
As expected from its effect on cyclin levels, Sam68 overex-
pression reduced phosphorylation of Rb (determined
with an anti-phospho-Rb antibody) in cells treated with
serum for 10 or 15 h, and completely abolished it in cells
released from mitosis for 10 h (Fig. 3A, bottom panel). To
confirm that the reduced Rb phosphorylation was due to
decreased G1 Cdk activation, we measured the activities of
Cdk2 and Cdk4 in immune complex kinase assays (Fig.
3B). Cyclin E-associated Cdk2 activity increased 6 and 9 h
after exiting mitosis, and this was completely blocked by
Sam68 overexpression (Fig. 3B, top panel). Immunoblot-
ting of the anti-cyclin E immunoprecipitates with anti-
Cdk2 confirmed that only the downshifted, activatedBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/5
Page 5 of 12
(page number not for citation purposes)
Sam68 overexpression inhibits G1 to S phase progression and decreases G1 cyclin levels Figure 2
Sam68 overexpression inhibits G1 to S phase progression and decreases G1 cyclin levels. A. Cells in the presence 
or absence of doxycycline were synchronized in mitosis by nocodazole treatment and released into G1 phase by drug washout. 
Cells were lysed in SDS-PAGE sample buffer 8 h after release and lysates were immunoblotted with the indicated antibodies. 
BrdU incorporation was assessed 24 h after release and quantitated by flow cytometry. B. Cells were released from mitosis 
and total RNA was prepared at the indicated times. Levels of the indicated transcripts were determined by RT-PCR with spe-
cific primers. Results are representative of three separate experiments.
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Sam68 overexpression decreases G1 Cdk activities and Rb phosphorylation Figure 3
Sam68 overexpression decreases G1 Cdk activities and Rb phosphorylation. A. Cells were synchronized in mitosis 
by nocodazole treatment or in G0 by serum deprivation and released into G1 by drug removal or serum replacement, respec-
tively. At the indicated times after release cells were lysed in 3T3 lysis buffer and immunoblotted with antibodies against 
Sam68, cyclin D1, cyclin E, Cdk2 or phospho-Rb. B. Lysates from cells released from mitosis for the indicated times were sub-
jected to immunoprecipitation with anti-cyclin E or -Cdk4 antibodies. Immunoprecipitates were assayed for in vitro kinase activ-
ity (KA) with histone H1 or GST-Rb as substrates, respectively. Indicated below the Cdk4 assay gel are relative 32P 
incorporations into Rb per lane, as determined by phosphorimager analysis. Whole cell lysates (WCL) or immunoprecipitates 
(IP) were also Western blotted (WB) with anti-Cdk2 antibodies. Results are representative of three separate experiments.
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form of Cdk2 was co-immunoprecipitated and that this
form was greatly diminished in cells overexpressing
Sam68 (Fig. 3B, third panel). Overexpression of Sam68
caused a less striking, but reproducible, decrease in Cdk4
activity after release from mitosis (53% activity at 9 h after
mitosis in anti-Cdk4 immunoprecipitates from cells over-
expressing Sam68 compared to uninduced cells; Fig. 3B,
bottom panel). In summary, overexpression of Sam68
arrests or delays progression through G1. This is associ-
ated with reduced G1 cyclin levels and Rb phosphoryla-
tion and does not require specific RNA binding. The
kinetics of cyclin reduction, which precedes S phase, are
consistent with this being responsible for the decrease in
Rb phosphorylation and consequent G1 arrest.
Sam68 induces apoptosis by a mechanism requiring 
specific RNA binding
As shown in Fig. 1B, overexpression of wt, but not spe-
cific-RNA binding-defective Sam68 caused cell death as
well as proliferative arrest. In the absence of doxycycline a
substantial number of Sam68 tet-off cells underwent
nuclear condensation within 24 h, revealed by DAPI stain-
ing, indicative of apoptosis (Fig. 4A). As an alternative,
more quantitative measure of apoptosis we used a cell-
based fluorescence assay of caspase activation. Induction
of Sam68 overexpression induced significant apoptosis
(i.e., a large fraction of caspase-positive cells) 72 h after
doxycycline removal (Fig. 4B). No caspase positive cells
were detectable in cells expressing the RNA binding-defec-
tive G178E mutant. The increase in caspase-positive cells
was matched by an increase in cells with sub-G1 DNA
content, revealed by propidium iodide staining. These
results show that wt, but not specific-RNA binding-defec-
tive, Sam68 strongly promotes apoptosis.
We were curious to see if any anti-cancer agents were able
to enhance Sam68-induced apoptosis. Of the drugs
screened, only trichostatin A (TSA) enhanced Sam68-
driven apoptosis: In the absence of Sam68 overexpres-
sion, TSA (200 nM for 16 h) did not cause apoptosis.
However, in cells overexpressing Sam68, TSA treatment
increased the fraction of apoptotic cells, as determined by
Annexin V-FITC binding, from 33% to 56% (Fig. 5). As
expected, Sam68G178E did not induce apoptosis, and
this was unaltered by TSA treatment.
Discussion
Despite abundant circumstantial clues to its cellular func-
tion, an understanding of the precise cellular role of
Sam68 and the significance of its RNA binding ability has
proved elusive. Among the processes that it appears to reg-
ulate are transcription, splicing, RNA export and transla-
tion. The possibility that Sam68 might play multiple roles
in gene expression is supported by the present study in
which we show that its effects on cell proliferation and
death are functionally separable.
We found that Sam68 compromises cell proliferation
without the need for specific RNA binding. At least part of
its proliferative block resulted from cell cycle arrest in G1
phase. This involved downregulation of cyclin D1 and E
transcripts, suggesting that transcription of these genes
was repressed. This effect was recapitulated by an specific-
RNA binding-defective mutant of Sam68, and is reminis-
cent of the findings of Hong et al. [21], who showed that
Sam68 expression can repress transcription of reporter
constructs in an RNA-binding-independent manner. It is
of course possible that cyclin RNA diminution is attribut-
able to post-transcriptional intervention by Sam68 since
modulation of RNA export, stability or translatability
could result in alteration of total RNA levels. However, the
effect of RNA-binding-defective mutants favors a tran-
scriptional repression interpretation. If so, it will be
important to assess whether Sam68 directly affects cyclin
transcription or acts upstream of transcription. A direct
effect on cyclin transcription could involve Sam68 interac-
tion with the transcriptional co-activator CBP [21] or with
hnRNP K [22]. So far we have not observed any effects of
Sam68 overexpression on potential upstream regulators
of cyclin transcription such as Ras/Erk signaling or AP-1
expression (our unpublished results).
It was previously reported that an apparent splice variant
of Sam68, in which part of the KH domain was deleted,
could block G1 progression and cyclin D1 accumulation
in NIH 3T3 cells, whereas wt Sam68 did not [26]. Clearly
this contrasts with our findings in which both wt and
mutant Sam68 block progression and cyclin D1 accumu-
lation. Also we have been unable to detect the reported
splice variant in NIH 3T3 cells. It is not clear why our
results differ.
In contrast to its effect on proliferation, induction of
apoptosis by Sam68 requires its RNA-binding ability. This
ability is required for other Sam68 functions as well: For
example, its ability to enhance the cytoplasmic utilization
of reporter constructs containing retroviral RRE or CTE
elements requires RNA-binding [20]. This enhancement
does not result from an effect on RNA export (as previ-
ously surmised) since it occurs without appreciable effect
on nuclear export or global transcript level. It has been
hypothesized that Sam68 "marks" the transcripts in a way
that directs their cytoplasmic fate [20]. It has also recently
been reported that Sam68 can regulate splicing in
response to phosphorylation by activated Erk [17]. Clearly
the identification of relevant RNA targets of Sam68 will be
important to elucidate its precise functions. A recent
report identified RNAs capable of binding to Sam68 [27].
Many of these possessed a motif identified by in vitroBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/5
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Sam68 overexpression induces apoptosis dependent on RNA binding Figure 4
Sam68 overexpression induces apoptosis dependent on RNA binding. A. Tet-off cells conditionally expressing wild-
type HA-Sam68 were cultured on coverslips in 10% serum with or without doxycycline for 24 h, fixed and stained with DAPI. 
B. Tet-off cell lines expressing the indicated Sam68 proteins were cultured in the presence or absence of doxycycline for 72 h 
and then assayed for caspase activation with a cell-permeable fluorescent caspase inhibitor, FAM-VAD-FMK (FVF). Fixed cells 
were counterstained prior to flow cytometry with propidium iodide (PI). Results with two different clones of cells expressing 
wt Sam68 are shown.
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selection procedures [9]. This lends some credence to their
authenticity, but also opens the question of whether such
strategies uncover true in vivo targets or reflect in vitro
binding.
Our findings suggest that Sam68 can act as a tumor sup-
pressor, and are consistent with a previous study showing
that antisense-treatment to reduce Sam68 levels trans-
forms 3T3 fibroblasts [24]. Interestingly we found that at
least one anti-cancer agent, TSA, potentiated the ability of
Sam68 to induce apoptosis. At the concentrations used,
TSA alone did not induce apoptosis, but it increased the
level of apoptosis in cells overexpressing Sam68. TSA
inhibits protein deacetylases and is generally assumed to
exert its effects by enhancing histone acetylation, thereby
relaxing transcriptional constraints. Sam68 overexpres-
sion did not have any detectable effect on the extent of
histone hyperacetylation induced by TSA (data not
shown), so it seems unlikely that Sam68 modulates TSA-
induced transcription. Rather, pro-apoptotic signals gen-
erated by Sam68 and TSA may synergize to enforce apop-
tosis. Although we have not detected reactivity of Sam68
with anti-acetyl lysine antibodies, since Sam68 associates
with the acetyltransferase CBP, the potential role of
acetylation in regulating Sam68 function bears closer
examination.
We and others have not observed cell status-dependent
modulation of Sam68 expression levels; e.g., in response
to cell cycle progression, growth factors or stress. We have
also not detected marked differences in its expression lev-
els in several human cancer cell lines. Thus, it would seem
Trichostatin A potentiates Sam68-induced apoptosis Figure 5
Trichostatin A potentiates Sam68-induced apoptosis. Tet-off cells conditionally expressing wt or G178E HA-Sam68 
were cultured with or without doxycycline and then with 200 nM TSA or DMSO. Apoptotic cells were detected by annexin V-
FITC binding and flow cytometry.
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most likely that Sam68 activity is regulated post-transla-
tionally. This regulation could be conferred by covalent
modification, allosteric modulation or changes in subnu-
clear localization. Sam68 is phosphorylated at C-terminal
tyrosine residues by Src family kinases and the nuclear
kinase Brk/Sik. These phosphorylations reduce its ability
to bind to RNA in vitro, so we would predict that tyrosine
phosphorylation by these kinases would decrease its abil-
ity to induce apoptosis. Indeed we have found that co-
expressing activated forms of Src or Brk does suppress
apoptosis in cells overexpressing Sam68. However, until
we are able to generate non-phosphorylatable, yet func-
tional, mutants of Sam68, it will not be possible to
determine whether this effect is attributable to Sam68
phosphorylation.
Serine/threonine phosphorylation may also be involved
in regulation of Sam68's pro-apoptotic function: it has
recently been shown that phosphorylation of Sam68 by
Erk enables Sam68 to regulate splice site selection in
CD44 pre-RNA [17]. Our results with the deacetylase
inhibitor also raise the possibility of regulation by acetyla-
tion. Sam68 is also dimethylated on arginine residues,
and this can influence its ability to interact with other pro-
teins [3].
Sam68 might also be allosterically regulated by its interac-
tions with multiple nuclear proteins. For example, it has
been reported that binding of hnRNP K inhibits Sam68's
ability to enhance export of RRE-containing messages
(Yang, et al. 2002). Finally, it is known that Sam68
assumes a distinctive, punctate subnuclear distribution in
certain cancer cell lines (Chen et al. 1999), and this might
influence its ability to execute its normal function. In light
of our results showing enhancement of Sam68 pro-apop-
totic ability by the anti-cancer agent TSA it will be impor-
tant to find out whether, and how, the functional status of
Sam68 is altered in cellular transformation.
Conclusion
Overexpression of Sam68 results in either cell cycle arrest
or apoptosis in mouse fibroblasts. Induction of apoptosis,
but not proliferative arrest, requires an intact specific-RNA
binding function of Sam68. The separable effects of
Sam68 on these key cellular events may in part explain the
many roles previously attributed to Sam68 in cellular and
viral function. The ability of Sam68 to provoke apoptosis
is enhanced by TSA, suggesting that Sam68 status may
influence the effectiveness of some anti-cancer drugs.
Methods
Cell lines and plasmids
cDNAs encoding HA-epitope-tagged Sam68 (wild-type or
G178E; [9] were cloned into the tet-inducible vector
pUHD-10-3. Conditional "tet-off" cell lines were gener-
ated by co-transfection of NIH 3T3 cells with pTetTak and
the drug-resistance plasmid pSV2neo. Stable cell lines were
selected in the presence of 400 µg/ml G418 and main-
tained in the presence of 100 ng/ml doxycycline to repress
expression from the CMV promoter. Single colonies were
selected for further study. For the key experiments pre-
sented at least two different clones were tested to exclude
clonal variation influences (in Fig. 4C results obtained
using two different clones expressing wt Sam68 are
shown). The particular clones of wt and RNA binding
defective Sam68 expressing cells used in the figures shown
were chosen based on approximately equal levels of
epitope-tagged protein expression. Expression levels of wt
and mutant HA-Sam68 varied in parallel, relative to
endogenous Sam68, depending on time of induction and
growth conditions. For instance, inducible expression was
lower in serum-starved cells (see Fig. 3A). Plasmids encod-
ing YFP-tagged Sam68 were constructed by cloning sam68
cDNA into pEYFP-C1 (Clontech).
Apoptosis and proliferation assays
Cells were synchronized in mitosis by nocodazole treat-
ment. Tet-off cells were trypsinized and plated in medium
without or with 0.1 ng/ml doxycycline for 6–8 h. (We
found that maintaining a low level of doxycycline was
important for efficient collection of mitotic cells,
presumably by preventing high levels of Sam68 expres-
sion and consequent cell cycle arrest prior to the mitotic
block.) Nocodazole (0.1 µg/ml) was added and mitotic
cells were collected by shake-off 13–15 h later. To release
cells from the mitotic block, cells were washed by centrif-
ugation three times with medium with or without doxycy-
cline and then plated in medium containing 10% serum
with or without 100 ng/ml doxycycline. Cells were either:
(1) lysed in 3T3 lysis buffer [1], without Na deoxycholate,
or SDS-PAGE sample buffer at the indicated times after
release or (2) BrdU was added 7 h after release and BrdU
incorporation was assessed 24 h after release as described
by the manufacturer (Roche) and quantitated by flow
cytometry.
Trichostatin A (TSA) treatment of cells was as follows:
Sam68 wt or G178E tet-off cells were incubated with or
without doxycycline for 48 h and then in medium con-
taining doxycycline with 200 nM TSA or dimethyl sulfox-
ide (DMSO) for 16 h. It was necessary to switch off HA-
Sam68 expression by including doxycycline in all samples
since we found that TSA treatment increased expression
from the regulatable CMV promoter, presumably by
increasing histone acetylation at the promoter.
Three methods were used to assess apoptosis: (1) Cells
were grown on coverslips, fixed in formaldehyde and
stained with 4',6-diamidino-2-phenylindole (DAPI) to
score condensed nuclei. (2) Caspase activity in whole cellsBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/5
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was determined using a fluorescent caspase inhibitor
(FAM-VAD-FMK) as described by the manufacturer
(Intergen). (3) Cells were fixed in 70% ethanol and
stained with propidium iodide prior to flow cytometry
analysis. Annexin V-FITC or -PE labeling of live cells was
performed according to manufacturer's protocols
(Pharmingen) and cells were analyzed by flow cytometry.
Flow cytometry data were analyzed and quantitated using
FlowJo software (TreeStar).
Protein, RNA and protein kinase assays
Protein expression levels were determined by Western
blotting with specific antibodies. RNA levels were
determined by RT-PCR. Reverse transcription was primed
with a mixture of oligo dT and random primers. The
number of PCR cycles required for quantitative assess-
ment of the amount of each transcript was determined
experimentally. 18S ribosomal RNA was used as a loading
control. PCR products were analyzed on agarose gels and
stained with ethidium bromide. Cyclin E-associated Cdk2
activity and Cdk4 activity were assayed by immunoprecip-
itation of cell lysates, prepared in 3T3 lysis buffer [1];
without Na deoxycholate, containing equal amounts of
total protein with anti-cyclin E (Santa Cruz Biotechnol-
ogy; sc-481) or anti-Cdk4 antibodies (Santa Cruz Biotech-
nology; sc-260). Immune complexes were incubated with
substrate and [γ-32P]ATP. Histone H1 (Sigma) and GST-
Rb (Santa Cruz Biotechnology) were used as substrates for
Cdk2 and Cdk4 kinase assays, respectively. The assays
were stopped by adding SDS-PAGE sample buffer, and
radioactive products were resolved by SDS-PAGE.
At least three similar experiments were performed to con-
firm each finding. All results shown are representative of
these multiple experiments.
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